EPCO-34. DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA BY INTEGRATIVE SINGLE-CELL GENOMICS
Spitzer A, Johnson K, Nomura M, Garofano L, Nehar-belaid D, Darnell N, Greenwald A, Bussema L, Oh Y, Varn F, D’Angelo F, Gritsch S, Anderson K, Migliozzi S, Castro L, Chowdhury T, Robine N, Reeves C, Park J, Lipsa A, Hertel F, Golebiewska A, Niclou S, Nusrat L, Kellet S, Das S, Moon H, Paek S, Bielle F, Laurenge A, Di Stefano A, Mathon B, Picca A, Sanson M, Tanaka S, Saito N, Ashley D, Keir S, Huse J, Yung W, Lasorella A, Iavarone A, Verhaak R, Tirosh I, Suvà M. EPCO-34. DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA BY INTEGRATIVE SINGLE-CELL GENOMICS. Neuro-Oncology 2024, 26: viii9-viii9. PMCID: PMC11553653, DOI: 10.1093/neuonc/noae165.0033.Peer-Reviewed Original ResearchMalignant cellsStandard-of-care therapyCell typesMalignant cell fractionIDH-wildtype glioblastomaTumor DNA sequencingRecurrent GBM specimensMesenchymal-like cellsAssociated with specific changesMGMT methylationCell statesTreatment responseSingle-cell genomicsComposition of cell typesSingle-nucleus RNA sequencingMalignant stateDistribution of cell typesRecurrent samplesGBM specimensLongitudinal cohortGlioblastomaDNA sequencesClinical annotationDeletion phenotypeCell fraction
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply